Literature DB >> 19587301

Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania.

Shannon E McGettigan1, Baofeng Hu, Kathleen Andreacchio, Irving Nachamkin, Paul H Edelstein.   

Abstract

CTX-M beta-lactamases were thought to be rare in the United States, but a recent study in Texas showed that up to 70% of extended-spectrum beta-lactamase (ESBL)-containing members of the Enterobacteriaceae family were CTX-M positive (J. S. Lewis, M. Herrera, B. Wickes, J. E. Patterson, and J. H. Jorgensen, Antimicrob. Agents Chemother. 51:4015-4021, 2007). We used PCR to detect CTX-M in all 291 extended-spectrum cephalosporin-resistant gram-negative bacteria isolated in our laboratory during 2007. Thirty (48%) Escherichia coli isolates, 6 (3%) Klebsiella sp. isolates, and 7 (100%) Proteus mirabilis isolates tested were CTX-M positive, with 15% of all Enterobacteriaceae tested being positive. The E. coli CTX-M groups were I (57%), IV (37%), II (3%), and not groupable (3%); three of the group IV isolates were positive for CTX-M-18, and three of the group I isolates were positive for CTX-M-15. One of seven positive P. mirabilis isolates was in group II, with the remainder being positive for a CTX-M-25-like beta-lactamase; and 33% of the Klebsiella sp. isolates were in group I or IV, with the remainder not being in groups I to IV. CTX-M-producing bacteria were isolated from urine (n = 13), blood (n = 13), wounds (n = 12), and the respiratory tract (n = 4). All 31 CTX-M-positive isolates tested for the presence of ESBL were confirmed to produce ESBLs by the use of tests recommended by the CLSI. Pulsed-field gel electrophoresis of the CTX-M-positive isolates showed that six P. mirabilis isolates were clonal and that there were seven different E. coli clusters. Five of seven P. mirabilis isolates were from blood cultures. The CLSI tests for the confirmation of ESBL production reliably detect these isolates if both cefotaxime and ceftazidime are tested, but only about half would be classified as a possible CTX-M producers on the basis of the antibiogram alone. A new panprimer set increases the ability to detect CTX-M-producing strains. CTX-M-positive bacteria are common in our geographic region, are often invasive, and, with the exception of P. mirabilis, are multiclonal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587301      PMCID: PMC2738063          DOI: 10.1128/JCM.00319-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five US States.

Authors:  E Smith Moland; J A Black; A Hossain; N D Hanson; K S Thomson; S Pottumarthy
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 3.  CTX-M: changing the face of ESBLs in Europe.

Authors:  David M Livermore; Rafael Canton; Marek Gniadkowski; Patrice Nordmann; Gian Maria Rossolini; Guillaume Arlet; Juan Ayala; Teresa M Coque; Izabela Kern-Zdanowicz; Francesco Luzzaro; Laurent Poirel; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2006-12-06       Impact factor: 5.790

Review 4.  The spread of CTX-M-type extended-spectrum beta-lactamases.

Authors:  G M Rossolini; M M D'Andrea; C Mugnaioli
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

5.  Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).

Authors:  Mariana Castanheira; Rodrigo E Mendes; Paul R Rhomberg; Ronald N Jones
Journal:  Microb Drug Resist       Date:  2008-09       Impact factor: 3.431

6.  Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.

Authors:  Ana Mena; Virginia Plasencia; Laura García; Olga Hidalgo; José Ignacio Ayestarán; Sebastián Alberti; Nuria Borrell; José L Pérez; Antonio Oliver
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.

Authors:  Ebbing Lautenbach; Neil O Fishman; Joshua P Metlay; Xiangqun Mao; Warren B Bilker; Pam Tolomeo; Irving Nachamkin
Journal:  J Infect Dis       Date:  2006-05-31       Impact factor: 5.226

8.  Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.

Authors:  Soichiro Kimura; Masaji Ishiguro; Yoshikazu Ishii; Jimena Alba; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.

Authors:  James S Lewis; Monica Herrera; Brian Wickes; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

10.  Molecular epidemiology of Proteus mirabilis infections of the catheterized urinary tract.

Authors:  N A Sabbuba; E Mahenthiralingam; D J Stickler
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

  10 in total
  19 in total

1.  Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.

Authors:  Z A Qureshi; D L Paterson; A Y Peleg; J M Adams-Haduch; K A Shutt; D L Pakstis; E Sordillo; B Polsky; G Sandkovsky; M K Bhussar; Y Doi
Journal:  Clin Microbiol Infect       Date:  2011-09-26       Impact factor: 8.067

2.  Pediatric multicenter evaluation of the Verigene gram-negative blood culture test for rapid detection of inpatient bacteremia involving gram-negative organisms, extended-spectrum beta-lactamases, and carbapenemases.

Authors:  K V Sullivan; B Deburger; S S Roundtree; C A Ventrola; D L Blecker-Shelly; J E Mortensen
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

3.  Diversity of β-lactamase-encoding genes in wastewater: bacteriophages as reporters.

Authors:  Melina Elizabeth Barrios; María Dolores Blanco Fernández; Robertina Viviana Cammarata; Carolina Torres; Pablo Power; Viviana Andrea Mbayed
Journal:  Arch Virol       Date:  2021-03-08       Impact factor: 2.574

4.  Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.

Authors:  Lakshmi Chandramohan; Paula A Revell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

5.  Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients.

Authors:  Jennifer H Han; Irving Nachamkin; Theoklis E Zaoutis; Susan E Coffin; Darren R Linkin; Neil O Fishman; Mark G Weiner; Baofeng Hu; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-10-23       Impact factor: 3.254

6.  Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli.

Authors:  Jennifer H Han; Kei Kasahara; Paul H Edelstein; Warren B Bilker; Ebbing Lautenbach
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

7.  Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations.

Authors:  Mona M Abdelkader; Khaled M Aboshanab; Marwa A El-Ashry; Mohammad M Aboulwafa
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

8.  Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.

Authors:  Judith A Anesi; Ebbing Lautenbach; Irving Nachamkin; Charles Garrigan; Warren B Bilker; Mary Wheeler; Pam Tolomeo; Jennifer H Han
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-28       Impact factor: 3.254

9.  Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.

Authors:  Hanna E Sidjabat; David L Paterson; Jennifer M Adams-Haduch; Lindsay Ewan; Anthony W Pasculle; Carlene A Muto; Guo-Bao Tian; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

10.  Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.

Authors:  Kayoko Hayakawa; Sureka Gattu; Dror Marchaim; Ashish Bhargava; Mohan Palla; Khaled Alshabani; Uma Mahesh Gudur; Harish Pulluru; Pradeep Bathina; Pranathi Rao Sundaragiri; Moumita Sarkar; Hari Kakarlapudi; Balaji Ramasamy; Priyanka Nanjireddy; Shah Mohin; Meenakshi Dasagi; Satya Datla; Vamsi Kuchipudi; Swetha Reddy; Shobha Shahani; Vijaya Upputuri; Satya Marrey; Vedavyas Gannamani; Nandhini Madhanagopal; Srinadh Annangi; Busani Sudha; Kalyan Srinivas Muppavarapu; Judy A Moshos; Paul R Lephart; Jason M Pogue; Karen Bush; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.